What is Medterra?
Founded in 2017 and headquartered in Irvine, California, Medterra has established itself as a vertically integrated manufacturer and retailer of high-quality CBD products. By focusing on transparency and rigorous testing standards, the company has carved out a distinct position in the consumer health market. Medterra operates at the intersection of pharmaceutical-grade manufacturing and direct-to-consumer retail, leveraging its supply chain to deliver consistent product quality. Its market position is defined by a robust distribution network that spans both digital storefronts and physical retail partnerships, allowing the firm to capture significant market share in the rapidly evolving hemp-derived wellness space.
How much funding has Medterra raised?
Medterra has raised a total of $2.5M across 2 funding rounds:
Debt
$1M
Debt
$1.5M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.5M led by PPP
Key Investors in Medterra
PPP
Public-Private Partnership
What's next for Medterra?
With the recent infusion of capital, Medterra is positioned to accelerate its strategic growth initiatives. The company is expected to prioritize the optimization of its manufacturing capabilities and the expansion of its retail distribution channels. Given the current enterprise-level funding context, the firm will likely focus on enhancing its product development pipeline and strengthening its brand equity to maintain a competitive edge. Future efforts will likely center on navigating the complex regulatory landscape of the CBD industry while scaling operations to meet increasing consumer demand for wellness-oriented products. This strategic trajectory suggests a focus on long-term sustainability and market leadership in the health and wellness sector.
See full Medterra company page
